Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Targeting of DNA Damage Response in Cancer
Wonyoung Choi, Eun Sook Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1701-1701
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities
Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14672-14672
Open Access | Times Cited: 74
New Horizons in Lung Cancer Management Through ATR/CHK1 Pathway Modulation
Riya Thapa, Obaid Afzal, Asif Ahmad Bhat, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 19, pp. 1807-1818
Open Access | Times Cited: 47
Cancer, metastasis, and the epigenome
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
PD-1/PD-L1 and DNA Damage Response in Cancer
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 530-530
Open Access | Times Cited: 22
The DNA damage checkpoint: A tale from budding yeast
Paolo Pizzul, Erika Casari, Marco Gnugnoli, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 31
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Defective DNA Repair: A Putative Nexus Linking Immunological Diseases, Neurodegenerative Disorders, and Cancer
Safaa Othman Andarawi, Ľudmila Vodičková, Anusha Uttarilli, et al.
Mutagenesis (2025)
Closed Access
Unraveling BRAF alterations: molecular insights to circumvent therapeutic resistance across cancer types
Caterina Perfetto, Marianna Aprile, Simona Cataldi, et al.
Cancer Drug Resistance (2025)
Open Access
Hypoxia-Induced DNA Damage Response and Genomic Instability Dictate Cancer Treatment Response
Suniti Ahuja, Preeti Gupta, Gnana Ajay, et al.
(2025), pp. 47-76
Closed Access
Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer
Bhoomi Tarapara, Franky D. Shah
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis
Viola Melone, Annamaria Salvati, Domenico Palumbo, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 20
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy
Kristina Viktorsson, Thorsten Rieckmann, Maximilian Fleischmann, et al.
Strahlentherapie und Onkologie (2023) Vol. 199, Iss. 12, pp. 1091-1109
Open Access | Times Cited: 12
Baicalein Induces G2/M Cell Cycle Arrest Associated with ROS Generation and CHK2 Activation in Highly Invasive Human Ovarian Cancer Cells
Tzu‐Chao Chuang, Wei‐Syun Shao, Shih‐Chung Hsu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1039-1039
Open Access | Times Cited: 11
Distinct regulation of ATM signaling by DNA single-strand breaks and APE1
Haichao Zhao, Jia Li, Zhongsheng You, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
The roles of lncRNAs in the development of drug resistance of oral cancers
Wenjing Wang, Yi Liu, Jianan Wu
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117458-117458
Open Access | Times Cited: 4
Multilevel Mechanisms of Cancer Drug Resistance
Małgorzata Roszkowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12402-12402
Open Access | Times Cited: 3
The evolving role of DNA damage response in overcoming therapeutic resistance in ovarian cancer
Sara Bouberhan, Liron Bar‐Peled, Yusuke Matoba, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 2, pp. 345-357
Open Access | Times Cited: 8
Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer
Amy K. Wehn, Ping Qiu, Jared Lunceford, et al.
Gynecologic Oncology (2024) Vol. 184, pp. 67-73
Open Access | Times Cited: 2
Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy
Sophia Zhao, Daniel Prior, Christine M. Heske, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1648-1648
Open Access | Times Cited: 2
DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1
Rakesh Srivastava, Niraj Lodhi
Biomolecules (2022) Vol. 12, Iss. 3, pp. 417-417
Open Access | Times Cited: 12
DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
Öykü Gönül Geyik, Giulia Anichini, Engı̇n Ulukaya, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1463-1463
Open Access | Times Cited: 11
Prevalence of homologous recombination biomarkers in multiple tumor types: an observational study
Chen Cai, Elisha J. Dettman, Wei Zhou, et al.
Future Oncology (2024) Vol. 20, Iss. 31, pp. 2357-2370
Closed Access | Times Cited: 1
Where Do We Stand in Targeted Therapy Against BRCA1/2 Deficient Cancers?
Zoe Manuel-Epstein
Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal (2024) Vol. 8, Iss. 8, pp. 1-11
Open Access | Times Cited: 1
Molecular dynamics of DNA repair and carcinogen interaction: Implications for cancer initiation, progression, and therapeutic strategies
Eman Alyafeai, Eskandar Qaed, Haitham Saad Al-mashriqi, et al.
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 829, pp. 111883-111883
Closed Access | Times Cited: 1
Targeting DNA damage response in pancreatic ductal adenocarcinoma: A review of preclinical and clinical evidence
Fatemeh Moosavi, Bahareh Hassani, Somayeh Nazari, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189185-189185
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top